Clinical Trials Directory

Trials / Completed

CompletedNCT02238379

Intranasal Oxytocin Administration and the Neural Correlates of Social and Non-Social Visual Perception

Oxytocin Pilot: Oxytocin and Face Perception

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Yale University · Academic / Other
Sex
Female
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to investigate the effects of oxytocin on social behavior and brain activity using EEG and the event-related potential (ERP) technique. The value of EEG is its high temporal specificity, enabling precision in the timing of social behavior to be addressed. In order to elicit social responses in the human brain, a variety of social and emotional visual stimuli will be presented during EEG recording, namely infant and adult faces and houses. Brain responses after intranasal oxytocin will then be compared with placebo, to examine the effect of intranasal oxytocin on central nervous system activity. We hypothesize that intranasal oxytocin will enhance the neural response to social stimuli (infant and adult faces) but not to non-social stimuli (houses).

Conditions

Interventions

TypeNameDescription
DRUGOxytocin24 International Units of Oxytocin in a Nasal Spray
OTHERPlaceboPlacebo will contain all ingredients except the active oxytocin in the Nasal Spray.

Timeline

Start date
2014-09-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-09-12
Last updated
2018-01-17
Results posted
2017-05-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02238379. Inclusion in this directory is not an endorsement.